DRAQ7™, a Unique Far‐Red Viability Dye Used as a Measurement of Cell Viability in Patient-Derived Glioblastoma Stem Cells
22 April 2015

Reliably assay cell health in 2D or 3D at end-point or in real-time using BioStatus’s far-red cell viability probe, DRAQ7. This application note demonstrates the use of DRAQ7 for the analysis of patient-derived glioblastoma stem cells cultures for personalised medicine.


     Page  1 Next 
Preserving and Reporting the Cellular Experience of Hypoxic Environments2 Feb 2015